Xiao-Yu Dai Selected Research

Xiao-Yu Dai Research Topics

4	Neoplasms (Cancer) 04/2020 - 05/2018
2	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2020
2	Hypertension (High Blood Pressure) 01/2022 - 01/2021
2	Chronic Renal Insufficiency 01/2022 - 05/2015
2	Pancreatitis 01/2022 - 01/2020
2	Colorectal Neoplasms (Colorectal Cancer) 10/2019 - 05/2018
2	Inflammation (Inflammations) 07/2018 - 05/2015
1	Ischemic Stroke 01/2024
1	Stroke (Strokes) 07/2023
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Kidney Diseases (Kidney Disease) 01/2022
1	Cerebral Infarction 03/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021
1	Neoplasm Metastasis (Metastasis) 04/2020
1	Ascites 01/2020
1	Kidney Neoplasms (Kidney Cancer) 01/2020
1	Wounds and Injuries (Trauma) 01/2020
1	Tendon Entrapment (Stenosing Tenosynovitis) 04/2019
1	Pain (Aches) 04/2019
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 07/2015
1	Lower Urinary Tract Symptoms 07/2015

1	Tissue Plasminogen Activator (Alteplase)FDA Link 07/2023
1	LDL CholesterolIBA 01/2022
1	Amino Acids FDA Link 01/2022
1	CholesterolIBA 01/2022
1	Proton Pump InhibitorsIBA 01/2022
1	LipidsIBA 01/2022
1	Pyruvate KinaseIBA 01/2021
1	salicylhydroxamic acid (SHAM)IBA 01/2021
1	Matrix Metalloproteinases (MMPs)IBA 01/2020
1	Uric Acid (Urate)IBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	XELOXIBA 10/2019
1	ThymineIBA 07/2018
1	AcidsIBA 07/2018
1	VenomsIBA 05/2018
1	SteroidsIBA 05/2018
1	Fluorouracil (Carac)FDA LinkGeneric 05/2018
1	bufalinIBA 05/2018
1	Proteins (Proteins, Gene)FDA Link 05/2015
1	aristolochic acid I (aristolochic acid)IBA 05/2015
1	CreatinineIBA 05/2015

2	Acupuncture Therapy 07/2023 - 03/2021
2	Drug Therapy (Chemotherapy) 04/2020 - 10/2019
2	Therapeutics 04/2019 - 07/2015
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2024
1	Radiofrequency Ablation 04/2020
1	Aftercare (After-Treatment) 04/2020
1	Hepatectomy 04/2020
1	Resuscitation 01/2020
1	Length of Stay 10/2019
1	Conservative Treatment 04/2019